Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $2.30 $3.38 Friday, 10th May 2024 CLLS stock ended at $3.06. This is 5.56% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 9.00% from a day low at $3.00 to a day high of $3.27.
90 days $2.30 $3.38
52 weeks $0.96 $3.77

Historical Cellectis S.A. prices

Date Open High Low Close Volume
Oct 21, 2016 $18.90 $19.26 $18.80 $19.00 131 800
Oct 20, 2016 $19.31 $19.41 $18.84 $19.06 167 600
Oct 19, 2016 $19.52 $19.56 $19.13 $19.55 86 600
Oct 18, 2016 $20.06 $20.09 $19.40 $19.55 166 400
Oct 17, 2016 $20.00 $20.09 $19.76 $19.91 63 700
Oct 14, 2016 $20.57 $20.61 $20.06 $20.11 74 200
Oct 13, 2016 $20.48 $20.93 $20.37 $20.47 115 800
Oct 12, 2016 $21.77 $21.77 $21.44 $21.51 110 000
Oct 11, 2016 $22.68 $22.83 $22.02 $22.09 109 200
Oct 10, 2016 $22.71 $23.26 $22.71 $22.91 42 300
Oct 07, 2016 $22.50 $23.16 $22.29 $22.72 100 700
Oct 06, 2016 $23.00 $23.11 $22.52 $22.65 53 200
Oct 05, 2016 $23.06 $23.72 $23.01 $23.10 94 700
Oct 04, 2016 $22.92 $23.29 $22.86 $23.00 66 400
Oct 03, 2016 $23.74 $23.77 $23.02 $23.24 118 700
Sep 30, 2016 $24.13 $24.33 $23.82 $24.08 68 900
Sep 29, 2016 $24.50 $24.55 $24.05 $24.07 90 200
Sep 28, 2016 $24.83 $25.08 $24.50 $24.97 58 300
Sep 27, 2016 $24.82 $25.11 $24.52 $24.62 109 100
Sep 26, 2016 $25.33 $25.74 $24.81 $24.82 98 300
Sep 23, 2016 $25.42 $25.71 $25.24 $25.45 59 000
Sep 22, 2016 $25.72 $25.97 $25.68 $25.72 37 600
Sep 21, 2016 $24.84 $25.26 $24.52 $25.26 60 700
Sep 20, 2016 $24.44 $24.79 $24.22 $24.66 167 400
Sep 19, 2016 $24.65 $24.70 $24.02 $24.39 114 300
Click to get the best stock tips daily for free!

About Cellectis S.A.

Cellectis S.A. Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALL... CLLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT